Drug safety issues continue to occur even with drugs that are approved after the completion of clinical studies. Drug-induced liver injury (DILI) is a major obstacle drug development, because primary site metabolism, and injuries caused during this process severe. Conventional in vitro human models, such as 2-dimensional hepatic cell lines, lack vivo physiological relevance, animal studies have...
